Get the Stockscreener App
0.155
86.97%
-1.035
Orgenesis Inc stock is traded at $0.155, with a volume of 505.
It is down -86.97% in the last 24 hours and down -86.97% over the past month.
See More
Previous Close:
$1.19
Open:
$0.155
24h Volume:
505
Relative Volume:
6.23
Market Cap:
$N/A
Revenue:
$662.00K
Net Income/Loss:
$-29.02M
P/E Ratio:
-0.0182
EPS:
-8.5
Net Cash Flow:
$-12.54M
1W Performance:
-86.97%
1M Performance:
-86.97%
6M Performance:
-86.97%
1Y Performance:
-86.10%
1-Day Range:
$0.155
$0.155
1-Week Range:
$0.155
$0.155
52-Week Range:
$0.155
$1.19
Orgenesis Inc Stock (ORGS) Company Profile
Compare ORGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGS
Orgenesis Inc
|
0.155 | 0 | 662.00K | -29.02M | -12.54M | -8.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Orgenesis Inc Stock (ORGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-18 | Initiated | Dawson James | Buy |
Orgenesis Inc Stock (ORGS) Latest News
Is Orgenesis Inc. (45O) stock a safe buy pre earnings2025 Earnings Surprises & Stock Timing and Entry Methods - Улправда
Retail Trends: Is Orgenesis Inc 45O stock a safe buy pre earnings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - moha.gov.vn
Aug Gainers: Is Orgenesis Inc 45O stock a safe buy pre earningsInflation Watch & Verified Swing Trading Watchlists - Bộ Nội Vụ
Top Companies Developing Cell Therapy Treatments For Diabetes in 2026 - BioInformant
Published on: 2025-12-23 22:10:30 - earlytimes.in
Regenerative Therapies Market Forecast Through 2032 - openPR.com
Statera Biopharma (NASDAQ:STAB) vs. Orgenesis (NASDAQ:ORGS) Financial Contrast - Defense World
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer - Business Wire
Is Oriental Culture Holding LTD a good long term investmentUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in
Financial Contrast: Pharmaxis (OTCMKTS:PXSLY) and Orgenesis (NASDAQ:ORGS) - Defense World
What analysts say about GoPro Inc stockResistance Zone Identification & Machine Learning Stock Picks, Daily - earlytimes.in
How Orgenesis Inc. (45O) stock trades in high volatility2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Is Orgenesis Inc. (45O) stock suitable for passive index fundsWeekly Gains Report & Precise Swing Trade Alerts - Newser
Apex Tech Acquisition Inc files for IPO of up to $60 million - marketscreener.com
Is Orgenesis Inc. (45O) stock protected from inflation2025 Retail Activity & Fast Exit Strategy with Risk Control - Newser
Will Orgenesis Inc. (45O) stock split increase liquidityJuly 2025 Outlook & Long-Term Safe Investment Ideas - Newser
How Orgenesis Inc. (45O) stock compares with top peersShort Setup & Accurate Entry/Exit Alerts - Newser
Why Orgenesis Inc. (45O) stock attracts HNW investorsJuly 2025 Final Week & Proven Capital Preservation Tips - Newser
Will Orgenesis Inc. (45O) stock beat international competition2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
Orgenesis (NASDAQ:ORGS) Stock Price Up 257.1% – Here’s Why - Defense World
Will Orgenesis Inc. (45O) stock gain from lower interest ratesProduct Launch & Verified Momentum Stock Alerts - newser.com
Is Orgenesis Inc. (45O) stock a buy during volatile marketsWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com
Why institutional investors increase stakes in Orgenesis Inc. (45O) stockJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
Why Orgenesis Inc. (45O) stock is a strong analyst pick2025 Momentum Check & Real-Time Market Trend Scan - newser.com
Is Orgenesis Inc. (45O) stock included in top ETFsMarket Growth Report & Community Verified Trade Alerts - newser.com
Orgenesis Inc Stock (ORGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.73%
0.92%
Cap:
|
Volume (24h):